. The neurotoxic action of kainate was discovered by Olney et al. (2) while they were extending their work on the neurotoxic action of glutamate. In addition to inducing lesions directly, kainate also triggers epileptiform activity and secondary brain injury that can be reduced by anticonvulsant drugs (3) . Thus, brain injury can be triggered even by a systemic administration of kainate (4). The excitatory amino acid neurotransmitter glutamate and oxidative stress are two of the mechanisms that, in concert, may lead to neuronal damage through the excessive production of reactive oxygen species (ROS)2 (5-7). The formation of ROS is exaggerated in pathologic conditions and in aging (8, 9 (17) . We decided to record and score the appearance of these behavioral signs within the 4 h period after kainate administration: no response is scored "0," head nodding is "I,' wet dog shaking is "II," piano playing is "III," clonic convulsions with rearing and falling-down episodes are "IV," and generalized convulsions with tonic extension episodes are "V." For a period of 4 h after kainate injections, the rats were continously observed by two examiners who were trained in evaluating and recording the animal's behavior, and who were blind for the experimental schedule.
Each animal was ascribed the highest score it reached during the observation period.
Biochemical-high-performance liquid chromatography (HPLC) assay Biochemical changes that follow kainate administration to rats include an increase in the brain tissue levels of serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) and a marked decrease in noradrenaline (NA) levels (18 with vehicle only, and five with melatonin only; these animals showed a score of "0".
D Control
Kainate
Hippocampus Pynform cortex Amygclala to kainate in the hippocampus, the pyriform cortex, and the amygdala. Figure  1 shows the effect of kainate on the morphology of the hippocampus. Treatment with melatonin reduced kainate-triggered neuronal loss (Fig.  1) . Cell damage in the pyriform cortex and in the amygdala was even more pronounced:
11 days after kainate injection, we found signs of tissue necrosis that was associated with gliosis. We evaluated the extent of kainate-induced injury and the effect of melatonin; the results are shown in Fig. 2 .
At early times after kainate injection, i.e., after 3 to 6 h, we observed no signs of neuronal loss in the hippocampus (data not shown). However, even at these early times we detected biochemical changes that were triggered by kainate.
For example, in the hippocampus the content of NA had already decreased 1 h after kainate, and the content of 5-HIAA increased significantly 4 h after kainate injection (Fig. 3A) . Melatonin prevented both the kainate-induced NA decrease and 5-HIAA increase (Fig. 3B) . 
DISCUSSION
The main finding of this study is that the pharmacological administration of melatonin to rats (10 mg/kg, cumulative dose) reduces the damaging consequences of the stimulation of a subtype of glutamate receptors in the brain. This finding is in line with our previous observation that melatonin is neuroprotective in primary neuronal cultures (13, 16 The FASEB lournal GIUSTI El AL. 2) excite certain neuronal pathways, which in turn may cause secondary excitotoxic damage; and 3) trigger seizures that could induce hypoxia and edema, and thus lead to tertiary brain damage (17) . Most of the tertiary damage could be reduced by an antioxidative mechanism.
However, secondary damage could also be affected, i.e., attenuated, by indirect mechanisms such as, for example, the activation of diazepam-sensitive GABA receptors (3). Although a direct effect of melatonin on GABA binding sites has been excluded in vitro, in vivo melatonin is capable of increasing GABA content and affecting GABA receptor activity (23, 24). Thus, it is possible that some of the protective action of melatonin might involve this indirect mechanism.
However, GABAmediated protection from secondary brain damage is more effective in the hippocampal injury than in the necrosis of the amygdala and the pyriform cortex (17) . In our experiments, melatonin significantly reduced the damage in these latter two brain regions. 
